Doesn't sound like it, I think after reading the announcement.
I've stated on here before that I have a daughter with the PWS condition, so similar that I cannot recall what the difference is to AS.
I'm hoping that NEU can take this to the end. The problem at the possible end of this study is how much is the drug going to cost.
Angelman trial, page-47
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.78 |
Change
-1.360(6.14%) |
Mkt cap ! $2.656B | |||
| Open | High | Low | Value | Volume |
| $22.06 | $22.11 | $20.63 | $8.616M | 407.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 593 | $20.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.78 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |